Medical and Scientific Translation Across Canada Contact us Français

Home/Documents/Investigator Brochure Translation

Investigator Brochure Translation

Mediwords translates investigator brochures for pharmaceutical and biotech sponsors and the CROs that run their studies. Nonclinical data, pharmacokinetics, safety information and guidance for investigators are translated by native medical translators with a background in pharmacology, then revised by a second linguist.

Get a quote
  • Annual updates
  • Pharmacology experts
  • Tables checked
Medical translator checking pharmacology tables in a translated investigator brochure

Trusted by healthcare and life sciences organizations

  • Dexcom logo, client of Mediwords
  • Canadian Cancer Society logo, client of Mediwords
  • Allianz logo, client of Mediwords
  • Sun Life logo, client of Mediwords
  • YMCA New Brunswick logo, client of Mediwords
  • Sinai Health logo, client of Mediwords

Translating Investigator Brochures for Clinical Research

Investigator brochures (IBs) bring together the nonclinical and clinical evidence that investigators need to understand an investigational product, its risks and the precautions described in a trial protocol. Mediwords translates IBs for pharmaceutical and biotech sponsors, CROs and research organizations, preserving pharmacology terminology, safety information, numerical values and references across language versions.

An IB combines pharmaceutical properties, pharmacology, toxicology, pharmacokinetics and available clinical findings. Its readers include investigators and ethics committees, who use the document alongside the protocol and other study materials. Our role is accurate linguistic translation; scientific assessment, risk evaluation and approval of the final brochure remain with the sponsor and responsible clinical teams.

For drug clinical trial applications in Canada, Health Canada generally requests a current IB or applicable equivalent product information. Under Health Canada’s clinical trial application guidance, the IB should be reviewed at least annually and revised as needed. We support these translations and subsequent updates within our clinical trial translation services; the sponsor determines which versions must be submitted or distributed.

What an Investigator Brochure Contains

The internationally recognized ICH E6(R3) Good Clinical Practice guideline, Appendix A, describes the contents and purpose of an investigator’s brochure. We preserve the approved source structure and terminology while checking the following elements against the supplied original:

SectionWhat we watch in translation
Summary and introductionProduct name, code, class and indication consistent with the protocol
Physical, chemical and pharmaceutical propertiesChemical names, formulation, storage and handling instructions
Nonclinical studiesPharmacology, pharmacokinetics and toxicology terms, species, doses and units
Effects in humansPharmacokinetic parameters, efficacy results and adverse reactions from earlier studies
Summary of data and guidance for the investigatorSafety information, warnings, precautions and source reference safety information (RSI), where included; no independent expectedness assessment
Tables, figures and referencesTranslated headings, legends, footnotes and abbreviations compared against the source, with numerical values preserved

We maintain section numbers, table identifiers and source cross-references wherever the target layout permits. Your sponsor and document-control team remain responsible for approving the complete IB and its scientific content.

What Makes an IB Difficult to Translate

Scientific nomenclature

International nonproprietary names, development codes, chemical names and species names must be written exactly as in the source and your regulatory files.

Pharmacokinetic data

Parameters such as Cmax, AUC, half-life and clearance, with their units and decimal conventions, must not change in any way.

Toxicology vocabulary

Findings from animal studies use precise terms for organs, lesions and severity grades that general medical translators rarely know.

Dense tables

Tables contain dense scientific data. We translate headers, legends, footnotes and abbreviations and compare reproduced values with the supplied source; we do not independently validate experimental results.

Reference safety information

Reference safety information, where present, has a specific role in safety assessment and may be subject to jurisdiction-specific requirements. We preserve its approved wording and flag ambiguities; the sponsor’s safety team determines expectedness and reporting obligations.

Abbreviations

An IB can contain more than a hundred abbreviations. We keep a list and decide with you which ones are translated and which stay in English.

Annual Updates and Version Control

ICH E6(R3) calls for investigator brochures to be reviewed at least annually and revised when necessary; important new safety information may require earlier communication. For each updated source version, we compare the approved files, identify changed passages and coordinate their translation using the existing study glossary and translation memory. Where source formats permit, we can supply both tracked changes and a clean translated edition for your document-control review.

Safety changes, including revisions to reference safety information where applicable, require particular attention to terminology. We check the translated wording against the source and approved references, including the protocol and relevant adverse event reports. Decisions about expectedness, regulatory notifications and whether to amend other study documents remain with the sponsor and its pharmacovigilance team.

Translators Who Know Pharmacology

We assign investigator brochures to translators who work regularly on nonclinical and clinical data, often the same specialists who handle our pharmaceutical translation projects, such as product monographs and regulatory documents. They know the difference between a no observed adverse effect level and a maximum tolerated dose, and how each is expressed in French.

We support both early-phase programmes, where nonclinical evidence may dominate the IB, and later-stage studies with extensive safety and clinical histories. The assignment is matched to the document’s therapeutic area and technical content, followed by independent linguistic revision. We also work with biotech companies preparing multilingual research documentation.

Investigator Brochure Terms in Canadian French

Examples of Canadian French terminology used in IBs, subject to the sponsor’s approved glossary and the context of each document:

EnglishCanadian French
investigational productproduit de recherche
no observed adverse effect level (NOAEL)dose sans effet nocif observé (DSENO)
maximum tolerated dosedose maximale tolérée
area under the curve (AUC)aire sous la courbe (ASC)
elimination half-lifedemi-vie d'élimination

Abbreviations are a choice to make early. Some sponsors keep English abbreviations such as AUC in French documents, others prefer the French forms. We follow your convention throughout.

IBs for Multinational Programs

English and Canadian French are among our principal language combinations, but Mediwords supports investigator brochure translation in more than 30 languages. For multinational programmes, we coordinate terminology across language versions, work from the same approved source edition and track updates so each translation reflects the changes authorized for that market or study site.

When an existing European French IB is available, we can assess whether a Canadian French adaptation is appropriate, reviewing terminology, conventions and revised source passages. The extent of adaptation depends on the quality of the existing translation, the intended audience and sponsor requirements; it is not automatically limited to a few word substitutions.

How We Translate Investigator Brochures

Our ISO 17100-aligned process, adapted to IBs:

  1. Preparation. We review the IB, the protocol and your existing terminology, and list abbreviations and product-specific terms.
  2. Translation. A native medical translator with a pharmacology background translates the text, tables and figures.
  3. Revision. A second medical translator checks every section against the source, including values and units.
  4. Final check. The project manager verifies numbering, cross-references, tables and formatting.
  5. Delivery. We provide the agreed files and formats, including tracked and clean versions for updates where feasible, with a certificate of translation accuracy on request.

Before work begins, we confirm the approved source edition, scope of tables and figures, reference safety information, target countries and requested file formats. Changes received during translation are logged for review, and your document-control team approves the final translated edition before regulatory submission or site distribution.

Confidentiality of Unpublished Data

An IB often contains data that has never been published, including nonclinical results and early clinical findings that are commercially sensitive. We sign your non-disclosure agreement before receiving the file if you wish, and only the linguists assigned to the project have access to it. At the end of the project, we follow your instructions on how translated files and working copies are stored or deleted.

What to Send Us for an Accurate Quote

  • The current IB: in Word if possible, with its edition number and date
  • The previous translated edition: if one exists, so we can translate only what changed
  • Your terminology: product glossary, protocol translation or approved regulatory texts
  • Target languages: and the countries or sites concerned
  • Your deadline: including the submission or distribution date

If this is a revised IB, please also indicate whether you need a complete retranslation, translation of changed passages or a comparison with an existing language version.

With these, we send a fixed price and a delivery date within one business day.

Investigator Brochure Translation FAQ

Who translates investigator brochures?

Native medical translators with a background in pharmacology and clinical research, followed by a second medical translator who revises the full text.

Can you translate only the changes in an IB update?

Yes. We compare the approved source editions and translate the revised passages while checking terminology and references in context. Where the file format permits, we can deliver tracked and clean versions for your document-control team to review.

Do you translate the tables and figures?

Yes. We translate headings, footnotes, legends and relevant abbreviations within the agreed scope, and check reproduced figures and values against the source. Scientific validation of the original data remains with the sponsor.

Will the IB terminology match our protocol and safety reports?

We use the approved study glossary and reference versions to keep terminology consistent across the IB, protocol, informed consent materials and safety reports. Any apparent differences in the source documents are flagged rather than silently changed.

Do you translate IBs into Canadian French?

Yes. Canadian French is a principal specialization, and we translate IBs for French-speaking investigators and sites. We also support more than 30 languages for multinational clinical research programmes.

Do you sign NDAs before receiving an IB?

Yes. We can sign your non-disclosure agreement before you send the file.

Can you work with our formatting and template?

Yes. We work in editable templates where available and preserve the approved structure, numbering, tables and references. Complex layouts or locked files may require separate desktop publishing or final checks in your document system.

Can you adapt a European French IB for Canadian sites?

Yes. We assess the existing French edition, then adapt terminology and conventions and translate revised material as required. The necessary scope depends on the quality of the prior translation and the sponsor’s approved terminology.

Can you translate an IB written in another language into English?

Yes. Sponsors outside North America sometimes write their IB in another language. We translate it into English for Canadian investigators, ethics boards and regulators, with the same two-linguist process.

Do you translate IBs for medical devices?

Yes. We translate investigator brochures and equivalent clinical investigation documentation for medical devices, adapting the terminology to the device and study. Applicable regulatory requirements and document titles depend on the jurisdiction and product.

Get a Quote for Your Investigator Brochure

Send us your IB, the previous translated edition if you have one, the target languages and your deadline. We reply within one business day with a fixed price and a delivery date. You can also write to us at info@mediwords.ca.